Physician profile
Jacob E Smith
NPI 1538249016
$1,021.62
in general payments reported to CMS, 2019-2025
12 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.47 · 2020: $131 · 2022: $291 · 2023: $350 · 2024: $59.84 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $518.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $275.92 | 2020-2022 | |
| Medtronic, INC. | $214.79 | 2022-2024 | Propel, Nim Vital, Pteye Parathyroid Detection System |
| Olympus America INC. | $157.36 | 2019-2023 | |
| Glaxosmithkline, LLC. | $84.85 | 2022-2025 | Nucala |
| Ethicon US, LLC | $53.92 | 2019-2024 | Echelon; Endopath, Harmonic |
| Acclarent, INC | $44.86 | 2023 | Acclarent Aera |
| Optinose US, INC. | $41.70 | 2022-2025 | |
| Acera Surgical, INC. | $41.56 | 2023 | Restrata Wound Matrix |
| Regeneron Healthcare Solutions, INC. | $38.70 | 2022-2024 | Dupixent |
| Inspire Medical Systems, INC. | $34.48 | 2025 | Inspire |
| Novartis Pharmaceuticals Corporation | $18.68 | 2019 | |
| Merck Sharp & Dohme LLC | $14.80 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.